Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing
- PMID: 28087170
- DOI: 10.1016/j.diagmicrobio.2016.12.014
Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing
Abstract
Background: The Clostridium difficile rate in symptomatic patients represents both those with C. difficile infection (CDI) and those with colonization. To predict the extent of CDI overdiagnosis, we compared the asymptomatic colonization rate to the symptomatic positivity rate in hospitalized patients using nucleic acid testing.
Methods: Between July 2014 and April 2015, formed stool samples were collected from asymptomatic patients after admission to 3 hospital wards at the Stanford Hospital. Stool samples from symptomatic patients with suspected CDI in the same wards were collected for testing per provider order. The GeneXpert C. difficile tcdB polymerase chain reaction (PCR) assay (Cepheid, Sunnyvale, CA, USA) was performed on all stool samples and PCR cycle threshold was used as a measure of genomic equivalents. Chart review was performed to obtain clinical history and medication exposure.
Results: We found an asymptomatic C. difficile carriage rate of 11.8% (43/365) (95% confidence interval [CI], 8.5-15.1%) and a positivity rate in symptomatic patients of 15.4% (54/351) (95% CI, 11.6-19.2%; P=0.19). The median PCR cycle thresholds was not significantly different between asymptomatic carriers and symptomatic positives (29.5 versus 27.3; P=0.07). Among asymptomatic patients, 11.6% (5/43) of carriers and 8.4% (27/322; P=0.56) of noncarriers subsequently became symptomatic CDI suspects within the same hospitalization. Single and multivariate analysis did not identify any demographic or clinical factors as being significantly associated with C. difficile carriage.
Conclusions: Asymptomatic C. difficile carriage rate was similar to symptomatic positivity rate. This suggests the majority of PCR-positive results in symptomatic patients are likely due to C. difficile colonization. Disease-specific biomarkers are needed to accurately diagnose patients with C. difficile disease.
Keywords: Asymptomatic; C. difficile; Carriage; Colonization; Infection.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.BMC Geriatr. 2016 Nov 15;16(1):185. doi: 10.1186/s12877-016-0358-3. BMC Geriatr. 2016. PMID: 27846818 Free PMC article.
-
Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.JAMA Intern Med. 2016 Jun 1;176(6):796-804. doi: 10.1001/jamainternmed.2016.0177. JAMA Intern Med. 2016. PMID: 27111806
-
Whole genome sequencing of toxigenic Clostridium difficile in asymptomatic carriers: insights into possible role in transmission.J Hosp Infect. 2019 Jun;102(2):125-134. doi: 10.1016/j.jhin.2018.10.012. Epub 2018 Oct 22. J Hosp Infect. 2019. PMID: 30359648
-
Asymptomatic Clostridium difficile colonization as a reservoir for Clostridium difficile infection.Expert Rev Anti Infect Ther. 2014 Aug;12(8):967-80. doi: 10.1586/14787210.2014.920252. Epub 2014 May 22. Expert Rev Anti Infect Ther. 2014. PMID: 24848084 Review.
-
Clinical impact of Clostridium difficile colonization.J Microbiol Immunol Infect. 2015 Jun;48(3):241-8. doi: 10.1016/j.jmii.2014.04.011. Epub 2014 Jun 2. J Microbiol Immunol Infect. 2015. PMID: 24890755 Review.
Cited by
-
Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients.Epidemiol Infect. 2019 Jan;147:e166. doi: 10.1017/S0950268819000554. Epidemiol Infect. 2019. PMID: 31063095 Free PMC article.
-
Sleeping with the enemy: Clostridium difficile infection in the intensive care unit.Crit Care. 2017 Oct 22;21(1):260. doi: 10.1186/s13054-017-1819-6. Crit Care. 2017. PMID: 29058580 Free PMC article. Review.
-
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):130-143. doi: 10.1097/MPG.0000000000002205. J Pediatr Gastroenterol Nutr. 2019. PMID: 30540704 Free PMC article.
-
[Analysis of Clostridioides difficile infection characteristics and risk factors in patients hospitalized for diarrhea in 3 university hospitals in a mid-south city of China].Nan Fang Yi Ke Da Xue Xue Bao. 2024 May 20;44(5):998-1003. doi: 10.12122/j.issn.1673-4254.2024.05.23. Nan Fang Yi Ke Da Xue Xue Bao. 2024. PMID: 38862459 Free PMC article. Chinese.
-
The Biotherapeutic Potential of Lactobacillus reuteri Characterized Using a Target-Specific Selection Process.Front Microbiol. 2020 Apr 15;11:532. doi: 10.3389/fmicb.2020.00532. eCollection 2020. Front Microbiol. 2020. PMID: 32351460 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous